AlphAIAlphAI — Financial news for AI agents
SEC EDGARAUG 132 min read$BWXT

Geveden Rex D sold $1.7M of BWXT

Geveden Rex D (President and CEO) sold 10,000 shares of BWX Technologies, Inc. (BWXT) at an average of $172.50 ($171.21–$174.22, $1.73M total) across 4 trades on 2026-08-12 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Geveden Rex D
Published Aug 13, 2026, 8:10 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 13, 2026, 8:21 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefInsider activity
Primary signal
$BWXT
Neutral
medium confidence
Mentioned
$BWXT
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$BWXTNeutralLow
01

Why it matters

The newest fact is the disclosed open-market sale amount, trade dates, and confirmation that it was executed under a pre-arranged 10b5-1 plan.

02

Market read

Traders may monitor insider activity for sentiment, but the 10b5-1 structure reduces the likelihood of a fundamental signal.

03

What to watch

The article does not disclose total insider ownership changes beyond the post-transaction share count, nor whether other insiders sold or bought around the same time.

Relevance 5/10Novelty 3/10Timing: SEC Form 4 filed after-hours on 2026-08-13, covering sales dated 2026-08-12.

Background

This is an SEC Form 4 insider transaction disclosure for BWX Technologies, filed by the company’s President and CEO.

Company-level read

Ticker impact

$BWXTNeutralMedium confidence
Context

BWX Technologies CEO Geveden Rex D sold about $1.73M of BWXT shares via an open-market sale under a pre-arranged 10b5-1 plan.

Expected impact

Likely limited near-term impact; any effect is more about optics than new fundamentals.

Evidence & confidence

The filing provides transaction size, dates, and 10b5-1 status, but no new operating, guidance, or regulatory information.

Market effects

Sector

No direct sector read-through; this is a single-company insider transaction disclosure.

Regional

None indicated.

Global

None indicated.

Counterpoint

What could challenge this read

Because the sale is under a pre-arranged 10b5-1 plan, it may reflect routine liquidity needs rather than bearish expectations.

Key entities

  • issuer
    BWX Technologies, Inc.

    Subject of the Form 4 insider sale by its President and CEO.

  • insider
    Geveden Rex D

    President and CEO who sold 10,000 shares across four trades.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

BWXT insider trading history →

Related articles

SEP 15
$BWXTMed

Jim Cramer Favors BWX Technologies (BWXT) Over Cameco (CCJ)

Jim Cramer prefers BWX Technologies (BWXT) over Cameco (CCJ) for nuclear power investment, citing BWXT's stronger recent performance and Cameco's longer-term potential. BWXT reported Q2 revenue of $901.6M, up 18% YoY, and raised 2026 guidance. Cameco's Q2 uranium segment revenue fell to C$252M from C$352M YoY, but maintained production outlook. Both companies saw increased hedge fund interest.

insidermonkey.com2 min
SEP 15
$BWXTHigh

BWXT Looks 4.3% Undervalued on GF Value™

Guggenheim initiated coverage on BWX Technologies (BWXT) with a Buy rating and $192 price target, citing its strategic nuclear sector position. GF Value™ indicates BWXT is 4.3% undervalued at $148.53 vs. $155.28 intrinsic value. The company has a GF Score™ of 93/100, strong growth, and profitability but faces insider selling and premium valuation concerns.

gurufocus.com2 min
SEP 14
$BWXTMed

Bwxt stock hits 52-week low at 146.1 USD

BWX Technologies Inc. (BWXT) stock hit a 52-week low of $145.91, down 40% from its high. Q2 2026 earnings beat estimates at $1.07 EPS, but revenue missed at $901.6M. Sales rose 18% YoY, and the company raised full-year free cash flow guidance to $345M-$360M. BWXT's backlog grew to $8.4B, up 40% YoY. Jefferies initiated coverage with a Buy rating, and Wells Fargo upgraded to Equal Weight.

uk.investing.com2 min
SEP 10
$BWXTMed

Can BWXT's Canadian Lab Role Strengthen Nuclear Services Growth?

BWX Technologies (BWXT) is expanding its nuclear services through a new Canadian lab management role via a joint venture. The contract began in December 2025, complementing BWXT's broader strategy. The Kinectrics acquisition, completed in May 2025, is key to this expansion. BWXT's commercial revenues grew 62.8% YoY to $853.1M in 2025, with Kinectrics contributing $231M. Analysts expect EPS growth of 18.45% and 10.73% for 2026 and 2027, respectively.

finance.yahoo.com2 min
SEP 7
$CCJMed

Jefferies Sees Cameco (CCJ) and BWXT as Winners in the Nuclear Boom

Jefferies initiated coverage of Cameco (CCJ) and BWXT (BWXT) with 'Buy' ratings, setting price targets of $138 and $181 respectively, citing strong long-term prospects in nuclear energy. CCJ, a major uranium producer, and BWXT, a nuclear reactor provider, are positioned to benefit from global and U.S. initiatives to expand nuclear capacity. Both companies face risks, including uranium price volatility for CCJ and execution challenges for BWXT.

finance.yahoo.com3 min
SEP 6
$BWXTHighAI 8/10

BWX Technologies Already Builds Reactors for the Navy. Why Is It Still the Cheapest Nuclear Stock?

BWX Technologies (NYSE: BWXT) is the lowest-valued nuclear stock despite its monopoly in supplying nuclear reactors and fuel to the U.S. Navy. Its Q2 revenue rose 18% YoY to $901.6M, with EPS up 5% to $1.07. The company has an $8.6B backlog and raised its yearly revenue guidance to $3.8B. BWX also expanded into commercial markets, with Q2 commercial revenue up 72% YoY to $303M.

currently.att.yahoo.com2 min